Husband platform offers men personalized supplement recommendations

The Husband platform does not offer genetic testing but does inform its supplement recommendations on insights from 26,000 DNA reports and patient blood work.
The Husband platform does not offer genetic testing but does inform its supplement recommendations on insights from 26,000 DNA reports and patient blood work. (@ MoMo Productions / Getty Images)

A new platform harnesses men’s blood work and provides DNA-based guidance to inform them about the supplements they should take to improve their health.

Launched this month, Husband Vitamins is the creation of Bryce Wylde, one of Canada’s most prominent alternative health experts and co-founder of The DNA Company, which conducts DNA testing services covering a wide range of health and wellness interests.

“While Husband doesn’t conduct genetic testing per se, we’ve used 25 years of insights and my work from over 26,000 reports at The DNA Company to inform how we design the Husband line of formulas, especially in supporting methylation, hormone, metabolic and detoxification pathways,” Wylde told NutraIngredients.

Naming the platform Husband is not just an appeal to men. Women are often the CEOs of their family’s health, at least in the traditional, nuclear sense of family. Wylde said that the Husband brand is strategic, targeting the female demographic instrumental in maintaining their spouse’s health.

[Women] will research every supplement. They will overhaul diets, manage appointments,” Wylde said. “But when it comes to their partners, I hear the same frustrated rhetoric, which is that ‘I can’t make him take care of himself…Something has to be bleeding, or their limb is cut off to get help.’”

According to the U.S. Department of Labor, women make approximately 80% of the health care decisions for their families. Women provide most of the informal care to spouses and other family and community members at a cost of $148 billion to $188 billion annually, according to the Family Caregiver Alliance.

The technology

Husband relies on an at-home dried blood spot test, the SiPhox Health Ultimate Panel, which is powered by the Massachusetts Institute of Technology. It is an engineered photonic biosensor tool that analyzes 50 clinical-grade biomarkers, including those for cardiovascular risk, nutrients and inflammation. The test is comparable to the accuracy of blood draws, Wylde noted.

Husband also factors for the methyl tetrahydrofolate reductase (MTHFR) enzyme, which is essential for DNA repair, detoxification, neurotransmitter synthesis and turning genes on or off. MTHFR is also the name of the gene that codes for this enzyme, and when there is a variation of this gene it can impair the body’s ability to convert folic acid into its active form.

“Without this conversion, individuals may accumulate homocysteine, a risk factor for heart and brain disease,” Wylde said. “While Husband doesn’t test genes directly, we’ve incorporated activated folate and a very complete methylation support complex [to our offerings] based on the insights from many thousands of genomic profiles I’ve personally reviewed.”

Husband also tests for oxidized LDL, lipoprotein(a), apolipoprotein B, particle size and high-sensitivity C-reactive protein to get a clearer picture of cardiovascular risk and how inflammation contributes to the way cholesterol deposits to the artery lining in the first place.

According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men in the United States. Clinicians incorporating Husband into their practices can use the blood work from patients’ at-home test kit with tools like carotid ultrasound that examine the lumen of the artery lining, providing quick, non-invasive and highly actionable insights into cardiovascular risk.

“It’s like a window into vascular aging and far more insightful than just a basic cholesterol number,” Wylde said. “Traditional cholesterol tests alone miss critical markers like apolipoprotein B, lipoprotein(a), and high-sensitivity C-reactive protein, which better predict plaque formation and inflammation. When paired with imaging like CIMT (Carotid Intima-Media Thickness), clinicians can assess both the biochemical and structural status of vascular health which informs earlier and more personalized interventions before symptoms ever appear.”